SDHB p.Arg46Gln
Variant summary
The NM_003000.3(SDHB):c.137G>A (p.Arg46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene SDHB is a tumor suppressor gene (CancerMine: 12 TSG, 1 driver citations). The gene SDHB is a cancer driver gene (CancerMine: 12 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.0000167 (AC=27) in the gnomAD database across 1,613,850 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000121. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000212994: This mutation has been shown to increase protein degradation and to reduce mutant protein half-life in transfected cell lines (Saxena N et al. J. Natl. Cancer Inst. 2016 Jan;108" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R46G: Pathogenic (ClinVar VariationId 12785, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R46?: Uncertain_significance (ClinVar VariationId 591278, 0 stars); p.R46P: Uncertain_significance (ClinVar VariationId 3756934, 1 star); p.R46= (synonymous): Likely_benign (ClinVar VariationId 1100244, 1 star); p.R46= (synonymous): Benign/Likely_benign (ClinVar VariationId 646758, 2 stars); p.R46= (synonymous): Likely_benign (ClinVar VariationId 937404, 1 star) The variant has been observed in cBioPortal in 12 samples across 8 studies and 4 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 9 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000012 — very rare (O3 supporting [+1]) | ||
| O4Enriched in somatic variant database | Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=12 | studies=8 | cancer types=4 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets. | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 121 pathogenic, 13 benign (OR vs. background: 45.0).; ±8 AA neighbourhood: 5 pathogenic, 2 benign (OR vs. background: 11.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.44 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | MANE Select | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: NP_002991.2 UniProt: | |
SDHB | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: NP_001394290.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | TSL:1MANE Select | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: ENSP00000364649.3 UniProt: | |
SDHB | c.182G>A p.Arg61Gln | missense | Exon 3 of 9 | Prot: ENSP00000519325.1 UniProt: | ||
SDHB | c.137G>A p.Arg46Gln | missense | Exon 2 of 8 | Prot: ENSP00000595680.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000132 | AC:2 | Hom:0 | AN:152060 | Cov:32 |
GnomAD2 exomes | AF: 0.00000398 | AC:1 | AN:251358 | ||
GnomAD4 exome | AF: 0.0000171 | AC:25 | Hom:0 | AN:1461790 | Cov:32 |
GnomAD4 genome | AF: 0.0000132 | AC:2 | Hom:0 | AN:152060 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000151 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000126 | AC:3 | Hom:0 | AN:238764 | |
Local & regional cohorts 2 sources | |||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000570 | AC:7 | Hom:0 | AN:122586 | |
UK10K | AF: 0.000264 | AC:2 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000299 | 2 | 66888 |
SCHEMA | 0.0000392 | 3 | 76580 | 0.00000751 | 1 | 133232 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 29 | |
AlphaMissense | Pathogenic | 0.93 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 33 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.93 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 0.97 | |
GPN-Star LLR | N/A | -7.1 | |
GPN-Star score | N/A | 7.1 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.57 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 0.95 | D |
Mutation Taster | N/A | 6/94 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.6 | H |
PhyloP100 | Uncertain | 7.1 | |
popEVE | Benign | -3.5 | |
PrimateAI | Uncertain | 0.55 | T |
PromoterAI | N/A | -0.023 | Neutral |
PROVEAN | Uncertain | -3.3 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.91 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0010 | D |
Varity_R | N/A | 0.94 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.